Pronto Diagnostics develops, produces, and distributes genetic testing kits that provide rapid and accurate assays for detecting polymorphisms in DNA sequences associated with genetic diseases and predisposition to disease. The company's kits, which test for more than 35 different DNA variants, are suitable for both small-scale and large-scale clinical genetic analysis. The kits meet the highest international quality production standards and have all received the European CE mark. In the complete genotyping format of the Pronto system, each mutation site is tested in two wells of a 96-well microtiter plate. Every sample is separately and internally controlled for each mutation tested. Results are clearly determined visually as well as analyzed by a standard ELISA reader. Pronto Diagnostics performs all operating and commercial activities for Aferrix, a diagnostic start-up specializing in the analysis of plasma iron levels.